Aardvark Therapeutics, Inc. Share Price
NASDAQ: AARD | Micro CapAardvark Therapeutics, Inc. Stock Performance
Aardvark Therapeutics, Inc. Share Price Today
As of 9 October 2026, Aardvark Therapeutics, Inc.'s share price is $4.83. The stock opened at $4.80, compared to its previous close of $4.96. During today's trading session, Aardvark Therapeutics, Inc.'s share price traded between $4.74 and $5.08, with an average price of $4.91. Over the past 52 weeks, the stock has recorded a high of $17.49 and a low of $3.36. In terms of performance, Aardvark Therapeutics, Inc.'s share price has declined by 10.80% over the last six months and is down 54.48% on a year-on-year basis.
Aardvark Therapeutics, Inc. Share Price Chart
Aardvark Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Aardvark Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Aardvark Therapeutics, Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
Aardvark Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $5.23 | $4.83 | -8.61% |
Sep 2026 | $6.22 | $5.29 | -20.53% |
Aug 2026 | $6.74 | $6.65 | +2.62% |
Jul 2026 | $5.76 | $6.48 | +12.60% |
Jun 2026 | $3.98 | $5.75 | +40.02% |
May 2026 | $5.17 | $4.11 | -24.10% |
Apr 2026 | $3.87 | $5.42 | +44.40% |
Mar 2026 | $5.72 | $3.75 | -70.20% |
Feb 2026 | $12.80 | $12.59 | -2.97% |
Jan 2026 | $12.60 | $12.97 | -0.92% |
Dec 2025 | $9.95 | $13.09 | +31.43% |
Nov 2025 | $10.41 | $9.96 | -6.13% |